HEADER HYDROLASE 07-OCT-03 1R4L TITLE INHIBITOR BOUND HUMAN ANGIOTENSIN CONVERTING ENZYME-RELATED TITLE 2 CARBOXYPEPTIDASE (ACE2) CAVEAT 1R4L NAG A 800 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN I CONVERTING ENZYME 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAINS; COMPND 5 SYNONYM: ANGIOTENSIN CONVERTING ENZYME-LIKE PROTEIN, ANGIOTENSIN COMPND 6 CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: DISORDERED SEGMENT OF COLLECTRIN HOMOLOGY DOMAIN; COMPND 10 CHAIN: B; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: DISORDERED SEGMENT OF COLLECTRIN HOMOLOGY DOMAIN; COMPND 14 CHAIN: C; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 4; COMPND 17 MOLECULE: DISORDERED SEGMENT OF COLLECTRIN HOMOLOGY DOMAIN; COMPND 18 CHAIN: D; COMPND 19 ENGINEERED: YES; COMPND 20 MOL_ID: 5; COMPND 21 MOLECULE: DISORDERED SEGMENT OF COLLECTRIN HOMOLOGY DOMAIN; COMPND 22 CHAIN: E; COMPND 23 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACE2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PBAC PAK9; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 GENE: ACE2; SOURCE 17 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 18 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 20 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 22 EXPRESSION_SYSTEM_VECTOR: PBAC PAK9; SOURCE 23 MOL_ID: 3; SOURCE 24 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 25 ORGANISM_COMMON: HUMAN; SOURCE 26 ORGANISM_TAXID: 9606; SOURCE 27 GENE: ACE2; SOURCE 28 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 29 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 30 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 31 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 32 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 33 EXPRESSION_SYSTEM_VECTOR: PBAC PAK9; SOURCE 34 MOL_ID: 4; SOURCE 35 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 36 ORGANISM_COMMON: HUMAN; SOURCE 37 ORGANISM_TAXID: 9606; SOURCE 38 GENE: ACE2; SOURCE 39 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 40 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 41 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 42 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 43 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 44 EXPRESSION_SYSTEM_VECTOR: PBAC PAK9; SOURCE 45 MOL_ID: 5; SOURCE 46 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 47 ORGANISM_COMMON: HUMAN; SOURCE 48 ORGANISM_TAXID: 9606; SOURCE 49 GENE: ACE2; SOURCE 50 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 51 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 52 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 53 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 54 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 55 EXPRESSION_SYSTEM_VECTOR: PBAC PAK9 KEYWDS ZINC METALLOPEPTIDASE DOMAIN, COLLECTRIN HOMOLOGY DOMAIN, INHIBITOR KEYWDS 2 BOUND CONFORMATION, CHLORIDE ION BINDING SITE, ZINC ION BINDING KEYWDS 3 SITE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR P.TOWLER,B.STAKER,S.G.PRASAD,S.MENON,D.RYAN,J.TANG,T.PARSONS, AUTHOR 2 M.FISHER,D.WILLIAMS,N.A.DALES,M.A.PATANE,M.W.PANTOLIANO REVDAT 7 23-AUG-23 1R4L 1 HETSYN REVDAT 6 29-JUL-20 1R4L 1 CAVEAT COMPND REMARK HETNAM REVDAT 6 2 1 LINK SITE REVDAT 5 13-JUL-11 1R4L 1 VERSN REVDAT 4 24-FEB-09 1R4L 1 VERSN REVDAT 3 04-MAY-04 1R4L 1 AUTHOR REVDAT 2 27-APR-04 1R4L 1 JRNL REVDAT 1 03-FEB-04 1R4L 0 JRNL AUTH P.TOWLER,B.STAKER,S.G.PRASAD,S.MENON,J.TANG,T.PARSONS, JRNL AUTH 2 D.RYAN,M.FISHER,D.WILLIAMS,N.A.DALES,M.A.PATANE, JRNL AUTH 3 M.W.PANTOLIANO JRNL TITL ACE2 X-RAY STRUCTURES REVEAL A LARGE HINGE-BENDING MOTION JRNL TITL 2 IMPORTANT FOR INHIBITOR BINDING AND CATALYSIS. JRNL REF J.BIOL.CHEM. V. 279 17996 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 14754895 JRNL DOI 10.1074/JBC.M311191200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH N.DALES,A.E.GOULD,J.A.BROWN,E.F.CALDERWOOD,B.GUAN,C.A.MINOR, REMARK 1 AUTH 2 J.M.GAVIN,P.HALES,V.K.KAUSHIK,M.STEWART,P.J.TUMMINO, REMARK 1 AUTH 3 C.S.VICKERS,T.D.OCAIN,M.A.PATANE REMARK 1 TITL SUBSTRATE BASED DESIGN OF THE FIRST CLASS OF REMARK 1 TITL 2 ANGIOTENSIN-CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE REMARK 1 TITL 3 (ACE2) INHIBITORS REMARK 1 REF J.AM.CHEM.SOC. V. 124 11852 2002 REMARK 1 REFN ISSN 0002-7863 REMARK 1 DOI 10.1021/JA0277226 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.VICKERS,P.HALES,V.KAUSHIK,L.DICK,J.GAVIN,J.TANG,K.GODBOUT, REMARK 1 AUTH 2 T.PARSONS,E.BARONAS,F.HSIEH,S.ACTON,M.PATANE,A.NICHOLS, REMARK 1 AUTH 3 P.TUMMINO REMARK 1 TITL HYDROLYSIS OF BIOLOGICAL PEPTIDES BY HUMAN REMARK 1 TITL 2 ANGIOTENSIN-CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE REMARK 1 REF J.BIOL.CHEM. V. 277 14838 2002 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.M200581200 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2938880.390 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 17228 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.253 REMARK 3 R VALUE (WORKING SET) : 0.253 REMARK 3 FREE R VALUE : 0.337 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1730 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2250 REMARK 3 BIN R VALUE (WORKING SET) : 0.3790 REMARK 3 BIN FREE R VALUE : 0.4600 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 247 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.029 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5147 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 13 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 63.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 74.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 20.07000 REMARK 3 B22 (A**2) : 15.00000 REMARK 3 B33 (A**2) : -35.07000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 20.30000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM SIGMAA (A) : 0.62 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.56 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.74 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.970 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.020 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.420 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.750 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.270 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 56.63 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : XX5_PAR.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : XX5_TOP.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1R4L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-OCT-03. REMARK 100 THE DEPOSITION ID IS D_1000020429. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17526 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07000 REMARK 200 FOR THE DATA SET : 13.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.23000 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1R42 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 19% PEG 3000, 100MM TRIS-HCL, 600MM REMARK 280 NACL, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 50.26550 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.25450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 50.26550 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 43.25450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 SER A 5 REMARK 465 TRP A 6 REMARK 465 LEU A 7 REMARK 465 LEU A 8 REMARK 465 LEU A 9 REMARK 465 SER A 10 REMARK 465 LEU A 11 REMARK 465 VAL A 12 REMARK 465 ALA A 13 REMARK 465 VAL A 14 REMARK 465 THR A 15 REMARK 465 ALA A 16 REMARK 465 ALA A 17 REMARK 465 GLN A 18 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 150 CG CD OE1 OE2 REMARK 470 PHE A 428 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 429 CG CD OE1 NE2 REMARK 470 GLU A 430 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HIS A 505 O ASP A 509 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH1 ARG A 582 NH1 ARG A 582 2655 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 20 162.60 -44.26 REMARK 500 GLU A 22 36.52 -82.55 REMARK 500 LYS A 26 -2.37 -56.76 REMARK 500 ASN A 51 3.29 -58.40 REMARK 500 ASN A 53 96.52 -167.11 REMARK 500 THR A 55 -93.07 -58.40 REMARK 500 GLU A 56 -48.81 169.65 REMARK 500 ASN A 63 31.84 -72.03 REMARK 500 GLN A 76 3.21 -64.09 REMARK 500 LEU A 79 5.92 -67.46 REMARK 500 GLN A 81 1.28 -66.44 REMARK 500 LEU A 85 -92.77 -40.32 REMARK 500 GLN A 86 -122.77 -62.04 REMARK 500 GLN A 89 -134.02 -101.76 REMARK 500 ASN A 90 62.33 21.25 REMARK 500 LEU A 91 -48.92 -5.94 REMARK 500 VAL A 93 -26.41 -38.82 REMARK 500 SER A 109 66.05 -60.86 REMARK 500 GLU A 110 -87.34 22.86 REMARK 500 ASP A 111 28.52 -70.82 REMARK 500 MET A 123 -46.87 -28.90 REMARK 500 THR A 129 -29.93 174.82 REMARK 500 ASN A 134 131.71 -37.87 REMARK 500 ASN A 137 79.77 -177.76 REMARK 500 PRO A 138 -11.01 -40.21 REMARK 500 MET A 152 -8.17 -56.96 REMARK 500 ASN A 154 -53.54 -124.39 REMARK 500 SER A 155 142.81 -37.98 REMARK 500 TYR A 158 -24.38 -34.16 REMARK 500 GLU A 171 -72.32 -63.05 REMARK 500 ARG A 177 -76.73 -28.67 REMARK 500 VAL A 185 -71.83 -54.41 REMARK 500 ALA A 191 -73.35 -59.65 REMARK 500 HIS A 195 31.04 77.28 REMARK 500 ASP A 198 -168.76 -177.71 REMARK 500 ASP A 206 -46.34 -24.32 REMARK 500 ASN A 210 -84.66 -120.53 REMARK 500 LEU A 222 -42.87 -27.80 REMARK 500 ILE A 223 -83.13 -60.32 REMARK 500 GLU A 224 -9.69 -49.21 REMARK 500 GLU A 227 -70.65 -48.48 REMARK 500 ALA A 246 -89.41 -74.38 REMARK 500 LYS A 247 -5.97 -43.74 REMARK 500 TYR A 252 45.69 -161.95 REMARK 500 SER A 254 0.76 84.68 REMARK 500 PRO A 258 26.64 -68.49 REMARK 500 ILE A 259 12.87 -154.38 REMARK 500 CYS A 261 111.55 14.10 REMARK 500 LEU A 262 158.15 -44.22 REMARK 500 MET A 270 -30.62 -26.22 REMARK 500 REMARK 500 THIS ENTRY HAS 138 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 510 0.09 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 803 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 374 NE2 REMARK 620 2 HIS A 378 NE2 106.4 REMARK 620 3 GLU A 402 OE1 97.4 95.8 REMARK 620 4 XX5 A 804 O3 114.2 87.0 146.2 REMARK 620 5 XX5 A 804 O1 140.9 108.8 95.5 52.3 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1R42 RELATED DB: PDB REMARK 900 NATIVE HUMAN ANGIOTENSIN CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE REMARK 900 (ACE2) REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE COMPLETE SEQUENCE CRYSTALLIZED BY THE AUTHORS REMARK 999 (RESIDUES 1-740 OF REFERENCE SEQUENCE GB 11225609) REMARK 999 IS AS FOLLOWS: REMARK 999 MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNY REMARK 999 NTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQ REMARK 999 QNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEIM REMARK 999 ANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYW REMARK 999 RGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPS REMARK 999 YISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQAWDAQ REMARK 999 RIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDF REMARK 999 RILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEI REMARK 999 MSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTLPFTYMLEK REMARK 999 WRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSND REMARK 999 YSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRL REMARK 999 GKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNKNSFVGWSTDWS REMARK 999 PYADQSIKVRISLKSALGDKAYEWNDNEMYLFRSSVAYAMRQYFLKVKNQ REMARK 999 MILFGEEDVRVANLKPRISFNFFVTAPKNVSDIIPRTEVEKAIRMSRSRIN REMARK 999 DAFRLNDNSLEFLGIQPTLGPPNQPPVS REMARK 999 THE ELECTRON DENSITY MAP FOR MUCH OF THE COLLECTRIN REMARK 999 HOMOLOGY DOMAIN (RESIDUES 616-740) IS WEAK. ONLY REMARK 999 ABOUT HALF OF THIS DOMAIN WAS VISIBLE IN THE ELECTRON REMARK 999 DENSITY MAP, AND WHAT CAN BE SEEN IS AMBIGUOUS DUE TO REMARK 999 TOPOLOGY AND CONNECTIVITY ISSUES. FOR THIS REASON, REMARK 999 RESIDUES BEGINNING AT 901 ARE LABELED AS UNKNOWN (UNK). REMARK 999 EACH SEGMENT OF UNKNOWN RESIDUES HAS BEEN ASSIGNED REMARK 999 A UNIQUE CHAIN ID. HOWEVER, IT SHOULD BE UNDERSTOOD REMARK 999 THAT ONLY ONE SEQUENCE (RESIDUES 1-740) WAS CRYSTALLIZED. DBREF 1R4L A 1 615 UNP Q9BYF1 ACE2_HUMAN 1 615 DBREF 1R4L B 901 906 PDB 1R4L 1R4L 901 906 DBREF 1R4L C 907 926 PDB 1R4L 1R4L 907 926 DBREF 1R4L D 927 944 PDB 1R4L 1R4L 927 944 DBREF 1R4L E 945 958 PDB 1R4L 1R4L 945 958 SEQRES 1 A 615 MET SER SER SER SER TRP LEU LEU LEU SER LEU VAL ALA SEQRES 2 A 615 VAL THR ALA ALA GLN SER THR ILE GLU GLU GLN ALA LYS SEQRES 3 A 615 THR PHE LEU ASP LYS PHE ASN HIS GLU ALA GLU ASP LEU SEQRES 4 A 615 PHE TYR GLN SER SER LEU ALA SER TRP ASN TYR ASN THR SEQRES 5 A 615 ASN ILE THR GLU GLU ASN VAL GLN ASN MET ASN ASN ALA SEQRES 6 A 615 GLY ASP LYS TRP SER ALA PHE LEU LYS GLU GLN SER THR SEQRES 7 A 615 LEU ALA GLN MET TYR PRO LEU GLN GLU ILE GLN ASN LEU SEQRES 8 A 615 THR VAL LYS LEU GLN LEU GLN ALA LEU GLN GLN ASN GLY SEQRES 9 A 615 SER SER VAL LEU SER GLU ASP LYS SER LYS ARG LEU ASN SEQRES 10 A 615 THR ILE LEU ASN THR MET SER THR ILE TYR SER THR GLY SEQRES 11 A 615 LYS VAL CYS ASN PRO ASP ASN PRO GLN GLU CYS LEU LEU SEQRES 12 A 615 LEU GLU PRO GLY LEU ASN GLU ILE MET ALA ASN SER LEU SEQRES 13 A 615 ASP TYR ASN GLU ARG LEU TRP ALA TRP GLU SER TRP ARG SEQRES 14 A 615 SER GLU VAL GLY LYS GLN LEU ARG PRO LEU TYR GLU GLU SEQRES 15 A 615 TYR VAL VAL LEU LYS ASN GLU MET ALA ARG ALA ASN HIS SEQRES 16 A 615 TYR GLU ASP TYR GLY ASP TYR TRP ARG GLY ASP TYR GLU SEQRES 17 A 615 VAL ASN GLY VAL ASP GLY TYR ASP TYR SER ARG GLY GLN SEQRES 18 A 615 LEU ILE GLU ASP VAL GLU HIS THR PHE GLU GLU ILE LYS SEQRES 19 A 615 PRO LEU TYR GLU HIS LEU HIS ALA TYR VAL ARG ALA LYS SEQRES 20 A 615 LEU MET ASN ALA TYR PRO SER TYR ILE SER PRO ILE GLY SEQRES 21 A 615 CYS LEU PRO ALA HIS LEU LEU GLY ASP MET TRP GLY ARG SEQRES 22 A 615 PHE TRP THR ASN LEU TYR SER LEU THR VAL PRO PHE GLY SEQRES 23 A 615 GLN LYS PRO ASN ILE ASP VAL THR ASP ALA MET VAL ASP SEQRES 24 A 615 GLN ALA TRP ASP ALA GLN ARG ILE PHE LYS GLU ALA GLU SEQRES 25 A 615 LYS PHE PHE VAL SER VAL GLY LEU PRO ASN MET THR GLN SEQRES 26 A 615 GLY PHE TRP GLU ASN SER MET LEU THR ASP PRO GLY ASN SEQRES 27 A 615 VAL GLN LYS ALA VAL CYS HIS PRO THR ALA TRP ASP LEU SEQRES 28 A 615 GLY LYS GLY ASP PHE ARG ILE LEU MET CYS THR LYS VAL SEQRES 29 A 615 THR MET ASP ASP PHE LEU THR ALA HIS HIS GLU MET GLY SEQRES 30 A 615 HIS ILE GLN TYR ASP MET ALA TYR ALA ALA GLN PRO PHE SEQRES 31 A 615 LEU LEU ARG ASN GLY ALA ASN GLU GLY PHE HIS GLU ALA SEQRES 32 A 615 VAL GLY GLU ILE MET SER LEU SER ALA ALA THR PRO LYS SEQRES 33 A 615 HIS LEU LYS SER ILE GLY LEU LEU SER PRO ASP PHE GLN SEQRES 34 A 615 GLU ASP ASN GLU THR GLU ILE ASN PHE LEU LEU LYS GLN SEQRES 35 A 615 ALA LEU THR ILE VAL GLY THR LEU PRO PHE THR TYR MET SEQRES 36 A 615 LEU GLU LYS TRP ARG TRP MET VAL PHE LYS GLY GLU ILE SEQRES 37 A 615 PRO LYS ASP GLN TRP MET LYS LYS TRP TRP GLU MET LYS SEQRES 38 A 615 ARG GLU ILE VAL GLY VAL VAL GLU PRO VAL PRO HIS ASP SEQRES 39 A 615 GLU THR TYR CYS ASP PRO ALA SER LEU PHE HIS VAL SER SEQRES 40 A 615 ASN ASP TYR SER PHE ILE ARG TYR TYR THR ARG THR LEU SEQRES 41 A 615 TYR GLN PHE GLN PHE GLN GLU ALA LEU CYS GLN ALA ALA SEQRES 42 A 615 LYS HIS GLU GLY PRO LEU HIS LYS CYS ASP ILE SER ASN SEQRES 43 A 615 SER THR GLU ALA GLY GLN LYS LEU PHE ASN MET LEU ARG SEQRES 44 A 615 LEU GLY LYS SER GLU PRO TRP THR LEU ALA LEU GLU ASN SEQRES 45 A 615 VAL VAL GLY ALA LYS ASN MET ASN VAL ARG PRO LEU LEU SEQRES 46 A 615 ASN TYR PHE GLU PRO LEU PHE THR TRP LEU LYS ASP GLN SEQRES 47 A 615 ASN LYS ASN SER PHE VAL GLY TRP SER THR ASP TRP SER SEQRES 48 A 615 PRO TYR ALA ASP SEQRES 1 B 6 UNK UNK UNK UNK UNK UNK SEQRES 1 C 20 UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK SEQRES 2 C 20 UNK UNK UNK UNK UNK UNK UNK SEQRES 1 D 18 UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK SEQRES 2 D 18 UNK UNK UNK UNK UNK SEQRES 1 E 14 UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK SEQRES 2 E 14 UNK MODRES 1R4L ASN A 90 ASN GLYCOSYLATION SITE MODRES 1R4L ASN A 103 ASN GLYCOSYLATION SITE HET NAG A 800 14 HET NAG A 801 14 HET CL A 802 1 HET ZN A 803 1 HET XX5 A 804 28 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CL CHLORIDE ION HETNAM ZN ZINC ION HETNAM XX5 (S,S)-2-{1-CARBOXY-2-[3-(3,5-DICHLORO-BENZYL)-3H- HETNAM 2 XX5 IMIDAZOL-4-YL]-ETHYLAMINO}-4-METHYL-PENTANOIC ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN XX5 MLN-4760 FORMUL 6 NAG 2(C8 H15 N O6) FORMUL 8 CL CL 1- FORMUL 9 ZN ZN 2+ FORMUL 10 XX5 C19 H23 CL2 N3 O4 FORMUL 11 HOH *13(H2 O) HELIX 1 1 GLN A 24 LEU A 29 1 6 HELIX 2 2 LEU A 29 ASN A 51 1 23 HELIX 3 3 GLU A 56 MET A 82 1 27 HELIX 4 4 ASN A 90 GLN A 102 1 13 HELIX 5 5 GLY A 104 LEU A 108 5 5 HELIX 6 6 LYS A 112 SER A 128 1 17 HELIX 7 7 GLY A 147 SER A 155 1 9 HELIX 8 8 ASP A 157 ALA A 193 1 37 HELIX 9 9 ASP A 198 ARG A 204 1 7 HELIX 10 10 GLY A 205 GLU A 208 5 4 HELIX 11 11 SER A 218 GLU A 232 1 15 HELIX 12 12 ILE A 233 ALA A 242 1 10 HELIX 13 13 ARG A 245 ASN A 250 1 6 HELIX 14 14 PHE A 274 LEU A 278 5 5 HELIX 15 15 MET A 297 ALA A 301 5 5 HELIX 16 16 ASP A 303 VAL A 316 1 14 HELIX 17 17 SER A 317 GLY A 319 5 3 HELIX 18 18 MET A 366 TYR A 385 1 20 HELIX 19 19 PRO A 389 ARG A 393 5 5 HELIX 20 20 ASN A 397 LEU A 410 1 14 HELIX 21 21 THR A 414 GLY A 422 1 9 HELIX 22 22 ASP A 431 GLY A 466 1 36 HELIX 23 23 PRO A 469 ASP A 471 5 3 HELIX 24 24 GLN A 472 ILE A 484 1 13 HELIX 25 25 CYS A 498 SER A 502 5 5 HELIX 26 26 ILE A 513 CYS A 530 1 18 HELIX 27 27 GLN A 531 ALA A 533 5 3 HELIX 28 28 PRO A 538 CYS A 542 5 5 HELIX 29 29 SER A 547 ARG A 559 1 13 HELIX 30 30 PRO A 565 VAL A 574 1 10 HELIX 31 31 VAL A 581 PHE A 588 1 8 HELIX 32 32 PHE A 588 LYS A 600 1 13 HELIX 33 33 UNK D 927 UNK D 942 1 16 HELIX 34 34 UNK E 949 UNK E 953 5 5 SHEET 1 A 2 VAL A 132 CYS A 133 0 SHEET 2 A 2 CYS A 141 LEU A 142 -1 O LEU A 142 N VAL A 132 SHEET 1 B 2 THR A 347 GLY A 352 0 SHEET 2 B 2 ASP A 355 LEU A 359 -1 O ASP A 355 N GLY A 352 SSBOND 1 CYS A 133 CYS A 141 1555 1555 2.05 SSBOND 2 CYS A 344 CYS A 361 1555 1555 2.04 SSBOND 3 CYS A 530 CYS A 542 1555 1555 2.03 LINK ND2 ASN A 90 C1 NAG A 800 1555 1555 1.45 LINK ND2 ASN A 103 C1 NAG A 801 1555 1555 1.46 LINK NE2 HIS A 374 ZN ZN A 803 1555 1555 2.05 LINK NE2 HIS A 378 ZN ZN A 803 1555 1555 2.32 LINK OE1 GLU A 402 ZN ZN A 803 1555 1555 2.05 LINK ZN ZN A 803 O3 XX5 A 804 1555 1555 2.62 LINK ZN ZN A 803 O1 XX5 A 804 1555 1555 2.04 CISPEP 1 GLU A 145 PRO A 146 0 -0.65 CRYST1 100.531 86.509 105.858 90.00 103.65 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009947 0.000000 0.002416 0.00000 SCALE2 0.000000 0.011559 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009721 0.00000